Novel N-terminal variant of human VDR - PubMed (original) (raw)
. 2001 Sep;15(9):1599-609.
doi: 10.1210/mend.15.9.0693.
Affiliations
- PMID: 11518809
- DOI: 10.1210/mend.15.9.0693
Novel N-terminal variant of human VDR
K L Sunn et al. Mol Endocrinol. 2001 Sep.
Abstract
The importance of N-terminal regions of nuclear hormone receptors in transcriptional regulation is increasingly recognized. As variant VDR gene transcripts indicated possible N-terminally extended receptors, we investigated their natural occurrence, transactivation capacity, and subcellular localization. A novel 54-kDa VDRB1 protein, in addition to the previously recognized 48-kDa VDRA form, was detected in human kidney tissue as well as in osteoblastic (MG63), intestinal (Int-407, DLD-1, and COLO 206F), and kidney epithelial (786) human cell lines by Western blots using isoform-specific and nonselective anti-VDR antibodies. VDRB1 was present at approximately one-third the level of VDRA. Isoform-specific VDRB1 expression constructs produced lower ligand-dependent transactivation than VDRA when transiently transfected with a vitamin D-responsive promoter into cell lines with low endogenous VDR. Intracellular localization patterns of the green fluorescent protein-tagged VDR isoforms differed. VDRB1 appeared as discrete intranuclear foci in the absence of 1,25-dihydroxyvitamin D3, whereas VDRA produced diffuse nuclear fluorescence. After 1,25-dihydroxyvitamin D3 treatment, both VDR isoforms exhibited similar diffuse nuclear signal. In the absence of 1,25-dihydroxyvitamin D3, the VDRB1 foci partially colocalized with SC-35 speckles and a subset of promyelocytic leukemia nuclear bodies. These data provide the first evidence of VDRB1, a novel N-terminally variant human VDR that is expressed at a level comparable to VDRA in human tissue and cell lines. It is characterized by reduced transactivation activity and a ligand-responsive speckled intranuclear localization. The intranuclear compartmentalization and altered functional activity of VDRB1 may mediate a specialized physiological role for this receptor isoform.
Similar articles
- Promoter-, cell-, and ligand-specific transactivation responses of the VDRB1 isoform.
Esteban LM, Fong C, Amr D, Cock TA, Allison SJ, Flanagan JL, Liddle C, Eisman JA, Gardiner EM. Esteban LM, et al. Biochem Biophys Res Commun. 2005 Aug 19;334(1):9-15. doi: 10.1016/j.bbrc.2005.06.054. Biochem Biophys Res Commun. 2005. PMID: 15992766 - FRAP analysis of nucleocytoplasmic dynamics of the vitamin D receptor splice variant VDRB1: preferential targeting to nuclear speckles.
Sunn KL, Eisman JA, Gardiner EM, Jans DA. Sunn KL, et al. Biochem J. 2005 Jun 1;388(Pt 2):509-14. doi: 10.1042/BJ20042040. Biochem J. 2005. PMID: 15689185 Free PMC article. - YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: relief of repression by CREB-binding protein.
Raval-Pandya M, Dhawan P, Barletta F, Christakos S. Raval-Pandya M, et al. Mol Endocrinol. 2001 Jun;15(6):1035-46. doi: 10.1210/mend.15.6.0651. Mol Endocrinol. 2001. PMID: 11376120 - Fine tuning of vitamin D receptor (VDR) activity by post-transcriptional and post-translational modifications.
Zenata O, Vrzal R. Zenata O, et al. Oncotarget. 2017 May 23;8(21):35390-35402. doi: 10.18632/oncotarget.15697. Oncotarget. 2017. PMID: 28427151 Free PMC article. Review. - The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR, Haussler CA, Jurutka PW, Thompson PD, Hsieh JC, Remus LS, Selznick SH, Whitfield GK. Haussler MR, et al. J Endocrinol. 1997 Sep;154 Suppl:S57-73. J Endocrinol. 1997. PMID: 9379138 Review.
Cited by
- The Role of Classical and Novel Forms of Vitamin D in the Pathogenesis and Progression of Nonmelanoma Skin Cancers.
Slominski AT, Brożyna AA, Zmijewski MA, Janjetovic Z, Kim TK, Slominski RM, Tuckey RC, Mason RS, Jetten AM, Guroji P, Reichrath J, Elmets C, Athar M. Slominski AT, et al. Adv Exp Med Biol. 2020;1268:257-283. doi: 10.1007/978-3-030-46227-7_13. Adv Exp Med Biol. 2020. PMID: 32918223 Free PMC article. Review. - Altered localization of retinoid X receptor alpha coincides with loss of retinoid responsiveness in human breast cancer MDA-MB-231 cells.
Tanaka T, Dancheck BL, Trifiletti LC, Birnkrant RE, Taylor BJ, Garfield SH, Thorgeirsson U, De Luca LM. Tanaka T, et al. Mol Cell Biol. 2004 May;24(9):3972-82. doi: 10.1128/MCB.24.9.3972-3982.2004. Mol Cell Biol. 2004. PMID: 15082790 Free PMC article. - Nucleo-cytoplasmic cycling of the vitamin D receptor in the enterocyte-like cell line, Caco-2.
Klopot A, Hance KW, Peleg S, Barsony J, Fleet JC. Klopot A, et al. J Cell Biochem. 2007 Feb 15;100(3):617-28. doi: 10.1002/jcb.21087. J Cell Biochem. 2007. PMID: 16960876 Free PMC article. - Conserved steroid hormone homology converges on nuclear factor κB to modulate inflammation in asthma.
Payne AS, Freishtat RJ. Payne AS, et al. J Investig Med. 2012 Jan;60(1):13-7. doi: 10.2310/JIM.0b013e31823d7989. J Investig Med. 2012. PMID: 22183120 Free PMC article. Review. - Alternatively spliced isoforms of the human constitutive androstane receptor.
Auerbach SS, Ramsden R, Stoner MA, Verlinde C, Hassett C, Omiecinski CJ. Auerbach SS, et al. Nucleic Acids Res. 2003 Jun 15;31(12):3194-207. doi: 10.1093/nar/gkg419. Nucleic Acids Res. 2003. PMID: 12799447 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous